Biocompatible substrates can be treated with factors, such as angiogenesis factors, cytokines, extracellular matrix components, and other bioactive materials or drugs, prior to implantation, before or after the biocompatible substrate is coated with cultured cells, e.g., to promote the formation of new tissue after implantation and to promote graft healing.